Xeljanz (ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults

September 2014

You'll see Xeljanz ( ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults.

Think of Xeljanz as an alternative to Humira (adalimumab).

Expect to see Xeljanz used in combination with methotrexate...or used alone when methotrexate can't be taken due to side effects.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Healthy Lifestyles helping patients with low health literacy
Vaccines more opportunities to help patients get flu shots
Supplements managing low potassium levels in patients on diuretics (hydrochlorothiazide, furosemide, etc)
Rheumatoid Arthritis Xeljanz (ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults
Cardiology Patients will ask if they should stop niacin (Niaspan, etc)
Antidepressants preventing errors when drugs are combined for treating depression
Vaccines You'll see an increase in orders for pneumococcal vaccine (Pneumovax 23, etc)
Oral Health if electric toothbrushes (Oral-B Professional Care, Sonicare, Spinbrush, etc) are worth the extra cost
ADHD whether ADHD stimulants (methylphenidate, etc) increase heart risk in children and adolescents
Smoking Cessation About one in six Canadian adults still use tobacco, and many will appreciate your help to improve their chance of quitting